Meeder Advisory Services, Inc. Iovance Biotherapeutics, Inc. Transaction History
Meeder Advisory Services, Inc.
- $1.67 Trillion
- Q1 2025
A detailed history of Meeder Advisory Services, Inc. transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Meeder Advisory Services, Inc. holds 15,208 shares of IOVA stock, worth $53,228. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,208Holding current value
$53,228% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IOVA
# of Institutions
345Shares Held
245MCall Options Held
2.53MPut Options Held
3.5M-
Vanguard Group Inc Valley Forge, PA27.5MShares$96.4 Million0.0% of portfolio
-
Mhr Fund Management LLC New York, NY24.4MShares$85.5 Million24.02% of portfolio
-
Perceptive Advisors LLC New York, NY22.1MShares$77.4 Million5.46% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$74.3 Million0.0% of portfolio
-
State Street Corp Boston, MA12.2MShares$42.9 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $552M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...